SAN CLEMENTE, Calif., Jan 26, 2010 (BUSINESS WIRE) -- A new clinical trial investigating the health benefits of acai, the antioxidant and vitamin-rich berry, is adding to the emerging scientific evidence of the fruit's ability to potentially reduce some metabolic risk factors associated with cardiovascular disease, diabetes and stroke. The latest study won top honors during the Scripps Center for Integrative Medicine on January 23 and revealed promising initial results for using Sambazon acai to improve vascular health, and lower fasting blood sugar levels.
"This pilot study demonstrated the ability of the Sambazon acai pulp product to significantly lower several markers of cardiovascular risk in a relatively short period of time. Given these promising results, and the biologically active components in the acai fruit, further study is merited," said Dr. Jay Udani, MD, CEO and Medical Director of Medicus Research, a leading contract research organization with functional food experience.
Medicus Research recently conducted a pilot study with 10 slightly overweight, but healthy adult male and female participants (representing 1/3 of the American population). Each study participant consumed 100 grams of Sambazon(R) acai frozen fruit pulp twice daily for one month. Researchers measured participants' baseline fasting plasma glucose, plasma insulin levels, lipid levels (total cholesterol, HDL, LDL, triglycerides), high sensitivity C-reactive protein and blood pressure. After 30 days of consuming Sambazon(R) acai, participants' fasting glucose, insulin, total cholesterol, and LDL (bad cholesterol) were significantly reduced, as compared to the baseline. In addition, post-prandial (between meals) increases in blood glucose levels were significantly reduced.
"While additional research is needed, this pilot study suggests that in otherwise healthy, overweight adults, daily consumption of acai reduces several markers of metabolic syndrome associated with an increased risk of diabetes, cardiovascular disease, and stroke," said Jack F. Bukowski, MD, Ph.D., a former Harvard professor and currently Director of the Nutritional Science Research Institute.
This study follows a recently published study showing that acai consumption lowers cholesterol and raises antioxidant activity in rats. Sambazon(R) is committed to scientific and nutritional research about acai and supported the Medicus clinical trial. Sambazon(R) Acai Pure Pulp Packs, which were used in the Medicus study, are a top selling frozen fruit item and available in finer grocery and natural food stores.
Sambazon is the global leader in acai. Founded in 2000 as the first company to bring the antioxidant-rich acai berry from the Amazon to North America, Sambazon's mission is to deliver high quality, organic acai products to the planet. Sambazon's product line of Organic Acai Juice and Smoothies, Frozen Acai Smoothie Packs and Sorbets and Acai Supplements are enjoyed by world-class athletes and health-conscious consumers everywhere. Products are available at major retail stores and juice bars across North America including Whole Foods, Publix, Kroger, HEB, Albertsons and Vitamin Shoppe. Sambazon is also a leader among organic foods and sustainable agriculture. In November of 2006, Sambazon was named a winner of the Secretary of State's Award for Corporate Excellence for helping to create worldwide awareness and demand for the acai fruit. Sambazon pioneered the first of its kind Fair Trade and Certified Organic supply chain of acai which benefits thousands of local families and protects the biodiversity of the Amazon Rainforest through sustainable agriculture. Sambazon is the largest vertically integrated supplier and marketer of acai products, controlling every step of the manufacturing process to ensure sustainable and organic origin of the fruit as well as the highest level quality, nutrition, taste. To learn more about Sambazon Acai and creating positive change in the Amazon and beyond please visit us at www.sambazon.com.